NEMA COORDINATES SAR OPS AT THE SCENE OF BUILDING COLLAPSE INVOLVING A THREE STOREY BUILDING UNDER CONSTRUCTION AT GUDU AREA OF FCT. (PHOTOS). #PRESS RELEASE.

Image
 NEMA COORDINATES SAR OPS AT THE SCENE OF BUILDING COLLAPSE INVOLVING A THREE STOREY BUILDING UNDER CONSTRUCTION AT GUDU AREA OF FCT At about 0945hrs on Saturday 16th May, 2026, the National Emergency Management Agency (NEMA) was alerted of a building collapse at Gudu District of FCT.  Critical stakeholders including Federal Fire, FCT Fire, NSCDC, NPF, FRSC and Federal Capital Territory Emergency Management Agency (FEMA) were activated while a response team of NEMA from the Abuja Operations Office led by the Head of Operations Mr Zakari Abubakar  and operatives from AYA Emergency Response Bay (ERAB) were deployed to the scene for quick response and coordination.  A reinforcement team  from NEMA Headquarters led by the Director Search and Response (DSAR) Air Cdre Bature Usman was also on ground to provide necessary backup and supervision. At the time of this report, the operation is still ongoing. However, sixteen (16) casualties have so far been evacuated to Aso...

RUSSIA ANNOUNCED FIRST mRNA-BASED CANCER VACCINE. (PHOTO).


 Russia has made a major medical breakthrough with the announcement of its first mRNA-based cancer vaccine, which will be available for free to patients starting early 2025. The development was confirmed by Andrey Kaprin, General Director of the Radiology Medical Research Center under the Russian Ministry of Health, during an interview with Radio Rossiya. Pre-clinical trials have shown that the vaccine effectively suppresses tumor growth and potential metastases, according to Alexander Gintsburg, Director of the Gamaleya National Research Center for Epidemiology and Microbiology. However, the name of the vaccine is yet to be disclosed.


The Russian government views this vaccine as a significant step in addressing the country’s rising cancer rates. In 2022 alone, over 635,000 new cancer cases were reported in Russia, with colon, breast, and lung cancers being the most prevalent. Earlier this year, President Vladimir Putin highlighted in a televised address that the country was nearing the creation of next-generation cancer vaccines and immunomodulatory drugs, promising hope for millions of patients.


Cancer vaccines, such as the one developed by Russia, work by stimulating the immune system to target cancer cells more effectively. These vaccines are designed to identify and attack tumor-specific proteins, slowing tumor growth or preventing recurrence. Similar advancements are being made globally, with vaccines like the HPV shot already proving effective in preventing cancers linked to viral infections, such as cervical cancer.


Russia’s achievement joins efforts by other nations in the race to develop personalized cancer vaccines. Earlier this year, researchers at the University of Florida tested a vaccine for glioblastoma, an aggressive brain cancer, and reported strong immune responses in patients. Meanwhile, in the UK, a personalized vaccine for melanoma has shown promising results, improving survival rates in patients. These advancements underline the global focus on innovative cancer treatments, which could redefine oncology in the near future.

Comments

Popular posts from this blog

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).